BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 31486687)

  • 1. An update on generalized pustular psoriasis.
    Gooderham MJ; Van Voorhees AS; Lebwohl MG
    Expert Rev Clin Immunol; 2019 Sep; 15(9):907-919. PubMed ID: 31486687
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized pustular psoriasis: current management status and unmet medical needs in Japan.
    Komine M; Morita A
    Expert Rev Clin Immunol; 2021 Sep; 17(9):1015-1027. PubMed ID: 34402355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
    Arakawa A; Ruzicka T; Prinz JC
    JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of generalized pustular psoriasis.
    Kodali N; Blanchard I; Kunamneni S; Lebwohl MG
    Exp Dermatol; 2023 Aug; 32(8):1204-1218. PubMed ID: 36779681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.
    Potestio L; Camela E; Cacciapuoti S; Martora F; Guerriero L; Fornaro L; Ruggiero A; Megna M
    Expert Opin Drug Saf; 2023; 22(11):1003-1010. PubMed ID: 37768729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
    Bernardo D; Thaçi D; Torres T
    Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of disease burden and clinical management for generalized pustular psoriasis in China.
    Lu J; Shi Y
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1023-1032. PubMed ID: 36040447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
    Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical advances in biological therapy for generalized pustular psoriasis: a review.
    Hsieh CY; Tsai TF
    Expert Opin Biol Ther; 2024; 24(1-2):37-50. PubMed ID: 38247394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
    Boehner A; Navarini AA; Eyerich K
    Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.
    Ho PH; Tsai TF
    J Dermatol; 2018 Nov; 45(11):1353-1356. PubMed ID: 30230584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.
    Burden AD
    Expert Rev Clin Immunol; 2023 May; 19(5):473-481. PubMed ID: 36960829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast].
    Song EJ; Liu C
    Clin Cosmet Investig Dermatol; 2023; 16():2911-2917. PubMed ID: 37915421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
    Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity.
    Samotij D; Szczęch J; Reich A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized pustular psoriasis-Dawn of a new era in targeted immunotherapy.
    Neuhauser R; Eyerich K; Boehner A
    Exp Dermatol; 2020 Nov; 29(11):1088-1096. PubMed ID: 32780422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM; Mohammad NA; Nanu NM; Tey KE; Chew SF
    Int J Dermatol; 2014 Jun; 53(6):676-84. PubMed ID: 23967807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.
    Krueger J; Puig L; Thaçi D
    Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):51-64. PubMed ID: 35061230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.